Ionis Pharmaceuticals Stock Market Value
| IONS Stock | USD 32.96 0.06 0.18% |
| Symbol | Ionis |
Ionis Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ionis Pharmaceuticals. If investors know Ionis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ionis Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.44) | Earnings Share (3.04) | Revenue Per Share | Quarterly Revenue Growth (0.30) | Return On Assets |
The market value of Ionis Pharmaceuticals is measured differently than its book value, which is the value of Ionis that is recorded on the company's balance sheet. Investors also form their own opinion of Ionis Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Ionis Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ionis Pharmaceuticals' market value can be influenced by many factors that don't directly affect Ionis Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ionis Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ionis Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ionis Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Ionis Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Ionis Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Ionis Pharmaceuticals.
| 12/17/2024 |
| 03/17/2025 |
If you would invest 0.00 in Ionis Pharmaceuticals on December 17, 2024 and sell it all today you would earn a total of 0.00 from holding Ionis Pharmaceuticals or generate 0.0% return on investment in Ionis Pharmaceuticals over 90 days. Ionis Pharmaceuticals is related to or competes with Arrowhead Pharmaceuticals, Biomarin Pharmaceutical, Incyte, Apellis Pharmaceuticals, Viking Therapeutics, Terns Pharmaceuticals, and Akero Therapeutics. Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States More
Ionis Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Ionis Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Ionis Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 10.86 | |||
| Value At Risk | (3.80) | |||
| Potential Upside | 4.42 |
Ionis Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ionis Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Ionis Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Ionis Pharmaceuticals historical prices to predict the future Ionis Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.10) | |||
| Total Risk Alpha | 0.1143 | |||
| Treynor Ratio | (0.22) |
Ionis Pharmaceuticals Backtested Returns
Ionis Pharmaceuticals holds Efficiency (Sharpe) Ratio of -0.0755, which attests that the entity had a -0.0755 % return per unit of risk over the last 3 months. Ionis Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Ionis Pharmaceuticals' Market Risk Adjusted Performance of (0.21), risk adjusted performance of (0.06), and Standard Deviation of 2.5 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.89, which attests to possible diversification benefits within a given portfolio. Ionis Pharmaceuticals returns are very sensitive to returns on the market. As the market goes up or down, Ionis Pharmaceuticals is expected to follow. At this point, Ionis Pharmaceuticals has a negative expected return of -0.19%. Please make sure to check out Ionis Pharmaceuticals' jensen alpha, skewness, as well as the relationship between the Skewness and day typical price , to decide if Ionis Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.37 |
Poor reverse predictability
Ionis Pharmaceuticals has poor reverse predictability. Overlapping area represents the amount of predictability between Ionis Pharmaceuticals time series from 17th of December 2024 to 31st of January 2025 and 31st of January 2025 to 17th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Ionis Pharmaceuticals price movement. The serial correlation of -0.37 indicates that just about 37.0% of current Ionis Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.37 | |
| Spearman Rank Test | -0.56 | |
| Residual Average | 0.0 | |
| Price Variance | 0.86 |
Ionis Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Ionis Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Ionis Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Ionis Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Ionis Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Ionis Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Ionis Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Ionis Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Ionis Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Ionis Pharmaceuticals Lagged Returns
When evaluating Ionis Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Ionis Pharmaceuticals stock have on its future price. Ionis Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Ionis Pharmaceuticals autocorrelation shows the relationship between Ionis Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Ionis Pharmaceuticals.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Ionis Stock Analysis
When running Ionis Pharmaceuticals' price analysis, check to measure Ionis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ionis Pharmaceuticals is operating at the current time. Most of Ionis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ionis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ionis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ionis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.